Profit Margin: Net Income as a portion of total sales revenue. Calculated as: Net Income / Total Revenues
Attovia Therapeutics, Inc. (ATTO) had Profit Margin of -4597.11% for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$0.45M |
|
$-20.69M |
|
-- |
|
$0.45M |
|
$22.25M |
|
$-21.80M |
|
$1.12M |
|
$-20.69M |
|
$-20.69M |
|
$-20.69M |
|
$-20.69M |
|
$-20.69M |
|
$-20.69M |
|
$-21.80M |
|
$-21.80M |
|
4.24M |
|
4.24M |
|
$-4.88 |
|
$-4.88 |
|
| Balance Sheet Financials | |
$118.40M |
|
$3.34M |
|
$9.95M |
|
$128.35M |
|
$12.62M |
|
-- |
|
$261.19M |
|
$273.81M |
|
$-145.46M |
|
$-145.46M |
|
$-145.46M |
|
4.53M |
|
| Cash Flow Statement Financials | |
$-34.93M |
|
$29.36M |
|
$-1.80M |
|
$40.60M |
|
$33.23M |
|
$-7.36M |
|
$1.38M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.39 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-4845.11% |
|
-4845.11% |
|
-- |
|
-4597.11% |
|
|
Profit Margin |
-4597.11% |
$-35.29M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
14.22% |
|
14.22% |
|
-16.12% |
|
14.22% |
|
$-32.12 |
|
$-8.33 |
|
$-8.24 |
|